Background/Objectives: Glioblastoma is an aggressive brain tumor with limited treatment options and significant resistance to conventional therapies. Methods: In this study, we explored the effects of combining curcumin treatment with clusterin inhibition on cell death in glioma cells. Results: We observed that the combination of clusterin silencing and curcumin treatment induces cell death. This combination therapy significantly elevated reactive oxygen species (ROS), triggering oxidative stress, which acted as a key upstream mediator of apoptosis. Elevated ROS levels were found to be associated with caspase activation, suggesting apoptosis as the primary mode of cell death. Furthermore, autophagy was induced as a complementary mechanism, with upregulation of LC3B contributing to the enhanced cytotoxic effects. Conclusions: The synergy between clusterin knockdown-induced senescence and curcumin's pro-apoptotic and pro-autophagic effects highlights a potential novel therapeutic strategy for gliomas. These findings underscore the potential of this combination therapy in overcoming glioma resistance and improving treatment outcomes through the dual induction of oxidative stress and cell death pathways.

Department of Physiology Faculty of Science Charles University 128 00 Prague Czech Republic

Zobrazit více v PubMed

Hirtz A., Rech F., Dubois-Pot-Schneider H., Dumond H. Astrocytoma: A Hormone-Sensitive Tumor? Int. J. Mol. Sci. 2020;21:9114. doi: 10.3390/ijms21239114. PubMed DOI PMC

Jagtap J.C., Parveen D., Shah R.D., Desai A., Bhosale D., Chugh A., Ranade D., Karnik S., Khedkar B., Mathur A., et al. Secretory prostate apoptosis response (Par)-4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen-induced cell death. FEBS Open Bio. 2015;5:8–19. doi: 10.1016/j.fob.2014.11.005. PubMed DOI PMC

Johnson D.R., O’Neill B.P. Glioblastoma survival in the United States before and during the temozolomide era. J. Neurooncol. 2012;107:359–364. doi: 10.1007/s11060-011-0749-4. PubMed DOI

Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J.B., Janzer R.C., Ludwin S.K., Allgeier A., Fisher B., Belanger K., et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–466. doi: 10.1016/S1470-2045(09)70025-7. PubMed DOI

Iacob G., Dinca E.B. Current data and strategy in glioblastoma multiforme. J. Med. Life. 2009;2:386–393. PubMed PMC

Alimohammadi E., Bagheri S.R., Taheri S., Dayani M., Abdi A. The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma multiforme: A meta-analysis and systematic review. Oncol. Rev. 2020;14:461. doi: 10.4081/oncol.2020.461. PubMed DOI PMC

Minniti G., Amelio D., Amichetti M., Salvati M., Muni R., Bozzao A., Lanzetta G., Scarpino S., Arcella A., Enrici R.M. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother. Oncol. 2010;97:377–381. doi: 10.1016/j.radonc.2010.08.020. PubMed DOI

Yu J.T., Tan L. The role of clusterin in Alzheimer’s disease: Pathways, pathogenesis, and therapy. Mol. Neurobiol. 2012;45:314–326. doi: 10.1007/s12035-012-8237-1. PubMed DOI

Foster E.M., Dangla-Valls A., Lovestone S., Ribe E.M., Buckley N.J. Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies. Front. Neurosci. 2019;13:164. doi: 10.3389/fnins.2019.00164. PubMed DOI PMC

Sensibar J.A., Sutkowski D.M., Raffo A., Buttyan R., Griswold M.D., Sylvester S.R., Kozlowski J.M., Lee C. Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin) Cancer Res. 1995;55:2431–2437. PubMed

Trougakos I.P., So A., Jansen B., Gleave M.E., Gonos E.S. Silencing Expression of the Clusterin/Apolipoprotein J Gene in Human Cancer Cells Using Small Interfering RNA Induces Spontaneous Apoptosis, Reduced Growth Ability, and Cell Sensitization to Genotoxic and Oxidative Stress. Cancer Res. 2004;64:1834–1842. doi: 10.1158/0008-5472.CAN-03-2664. PubMed DOI

Beer T.M., Hotte S.J., Saad F., Alekseev B., Matveev V., Fléchon A., Gravis G., Joly F., Chi K.N., Malik Z., et al. Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): A randomised, open-label, international, phase 3 trial. Lancet Oncol. 2017;18:1532–1542. PubMed

Mitsufuji S., Iwagami Y., Kobayashi S., Sasaki K., Yamada D., Tomimaru Y., Akita H., Asaoka T., Noda T., Gotoh K., et al. Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer. Ann. Surg. Oncol. 2022;29:4937–4946. doi: 10.1245/s10434-022-11668-0. PubMed DOI

Sultana P., Honc O., Hodny Z., Novotny J. Clusterin Deficiency Promotes Cellular Senescence in Human Astrocytes. Mol. Neurobiol. 2024;1862:5774–5786. doi: 10.1007/s12035-024-04650-2. PubMed DOI PMC

Sultana P., Novotny J. Clusterin: A double-edged sword in cancer and neurological disorders. EXCLI J. 2024;23:912–936. PubMed PMC

Unlu A., Nayir E., Dogukan Kalenderoglu M., Kirca O., Ozdogan M. Curcumin (Turmeric) and cancer. J. BUON. 2016;21:1050–1060. PubMed

Cherif H., Bisson D.G., Jarzem P., Weber M., Ouellet J.A., Haglund L. Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro. J. Clin. Med. 2019;29:433. doi: 10.3390/jcm8040433. PubMed DOI PMC

Dirsch V.M., Stuppner H., Vollmar A.M. The Griess assay: Suitable for a bio-guided fractionation of anti-inflammatory plant extracts? Planta Med. 1998;64:423–426. doi: 10.1055/s-2006-957473. PubMed DOI

Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004;4:181–189. doi: 10.1038/nri1312. PubMed DOI

Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev. 2007;87:245–313. doi: 10.1152/physrev.00044.2005. PubMed DOI

Radi R. Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine. Proc. Natl. Acad. Sci. USA. 2018;115:5839–5848. doi: 10.1073/pnas.1804932115. PubMed DOI PMC

Trougakos I.P., Gonos E.S. Clusterin/apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell Biol. 2002;34:1430–1448. doi: 10.1016/S1357-2725(02)00041-9. PubMed DOI

Ren X., Chang C., Qi T., Yang P., Wang Y., Zhou X., Guan F., Li X. Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration. Int. J. Mol. Sci. 2023;24:13413. doi: 10.3390/ijms241713413. PubMed DOI PMC

Zhu Y., Bu S. Curcumin Induces Autophagy, Apoptosis, and Cell Cycle Arrest in Human Pancreatic Cancer Cells. Evid. Based Complement. Alternat. Med. 2017;2017:5787218. doi: 10.1155/2017/5787218. PubMed DOI PMC

Lv Z.D., Liu X.P., Zhao W.J., Dong Q., Li F.N., Wang H.B., Kong B. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. Int. J. Clin. Exp. Pathol. 2014;7:2818–2824. PubMed PMC

Wu S.H., Hang L.W., Yang J.S., Chen H.Y., Lin H.Y., Chiang J.H., Lu C.C., Yang J.L., Lai T.Y., Ko Y.C., et al. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Res. 2010;30:2125–2133. PubMed

Ryskalin L., Biagioni F., Busceti C.L., Lazzeri G., Frati A., Fornai F. The Multi-Faceted Effect of Curcumin in Glioblastoma from Rescuing Cell Clearance to Autophagy-Independent Effects. Molecules. 2020;25:4839. doi: 10.3390/molecules25204839. PubMed DOI PMC

Wong S.C., Kamarudin M.N.A., Naidu R. Anticancer Mechanism of Curcumin on Human Glioblastoma. Nutrients. 2021;13:950. doi: 10.3390/nu13030950. PubMed DOI PMC

Gersey Z.C., Rodriguez G.A., Barbarite E., Sanchez A., Walters W.M., Ohaeto K.C., Komotar R.J., Graham R.M. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species. BMC Cancer. 2017;17:99. doi: 10.1186/s12885-017-3058-2. PubMed DOI PMC

Manica D., Silva G.B.D., Silva A.P.D., Marafon F., Maciel S., Bagatini M.D., Moreno M. Curcumin promotes apoptosis of human melanoma cells by caspase 3. Cell Biochem. Funct. 2023;41:1295–1304. doi: 10.1002/cbf.3863. PubMed DOI

Georgiou-Siafis S.K., Tsiftsoglou A.S. The Key Role of GSH in Keeping the Redox Balance in Mammalian Cells: Mechanisms and Significance of GSH in Detoxification via Formation of Conjugates. Antioxidants. 2023;12:1953. doi: 10.3390/antiox12111953. PubMed DOI PMC

Simin k., Dehghan G., Rashtbari S., Yekta R., Sheibani N. Synergistic inhibition of catalase activity by food colorants sunset yellow and curcumin: An experimental and MLSD simulation approach. Chem. Biol. Interact. 2019;311:108746. PubMed

Harris I.S., DeNicola G.M. The Complex Interplay between Antioxidants and ROS in Cancer. Trends Cell Biol. 2020;30:440–451. doi: 10.1016/j.tcb.2020.03.002. PubMed DOI

Maiti P., Scott J., Sengupta D., Al-Gharaibeh A., Dunbar G.L. Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells. Int. J. Mol. Sci. 2019;20:399. doi: 10.3390/ijms20020399. PubMed DOI PMC

Kuttikrishnan S., Siveen K.S., Prabhu K.S., Khan A.Q., Ahmed E.I., Akhtar S., Ali T.A., Merhi M., Dermime S., Steinhoff M., et al. Curcumin Induces Apoptotic Cell Death via Inhibition of PI3-Kinase/AKT Pathway in B-Precursor Acute Lymphoblastic Leukemia. Front. Oncol. 2019;9:484. doi: 10.3389/fonc.2019.00484. PubMed DOI PMC

Datta S.R., Brunet A., Greenberg M.E. Cellular survival: A play in three Akts. Genes Dev. 1999;13:2905–2927. doi: 10.1101/gad.13.22.2905. PubMed DOI

Van Opdenbosch N., Lamkanfi M. Caspases in Cell Death, Inflammation, and Disease. Immunity. 2019;50:1352–1364. doi: 10.1016/j.immuni.2019.05.020. PubMed DOI PMC

Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998;17:1675–1687. doi: 10.1093/emboj/17.6.1675. PubMed DOI PMC

Tanida I., Minematsu-Ikeguchi N., Ueno T., Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 2005;1:84–91. doi: 10.4161/auto.1.2.1697. PubMed DOI

Bin L., Takashi T., Kenji T., Tze Fang W., Mari T., Akiko K., Satoru N., Nobuo Y. Curcumin Induces Cross-Regulation Between Autophagy and Apoptosis in Uterine Leiomyosarcoma Cells. Int. J. Gynecol. Cancer. 2013;23:803–808. doi: 10.1097/IGC.0b013e31828c9581. PubMed DOI

Yang J., Ning J., Peng L., He D. Effect of curcumin on Bcl-2 and Bax expression in nude mice prostate cancer. Int. J. Clin. Exp. Pathol. 2015;8:9272–9278. PubMed PMC

Bava S.V., Puliappadamba V.T., Deepti A., Nair A., Karunagaran D., Anto R.J. Sensitization of Taxol-induced Apoptosis by Curcumin Involves Down-regulation of Nuclear Factor-κB and the Serine/Threonine Kinase Akt and Is Independent of Tubulin Polymerization. J. Biol. Chem. 2005;280:6301–6308. doi: 10.1074/jbc.M410647200. PubMed DOI

Wahnou H., El Kebbaj R., Liagre B., Sol V., Limami Y., Duval R.E. Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy. Pharmaceutics. 2025;17:114. doi: 10.3390/pharmaceutics17010114. PubMed DOI PMC

Aggarwal B.B., Sundaram C., Malani N., Ichikawa H. Curcumin: The Indian solid gold. Adv. Exp. Med. Biol. 2007;595:1–75. PubMed

Rodriguez G.A., Shah A.H., Gersey Z.C., Shah S.S., Bregy A., Komotar R.J., Graham R.M. Investigating the therapeutic role and molecular biology of curcumin as a treatment for glioblastoma. Ther. Adv. Med. Oncol. 2016;8:248–260. doi: 10.1177/1758834016643518. PubMed DOI PMC

Can Karaca A., Rezaei A., Qamar M., Assadpour E., Esatbeyoglu T., Jafari S.M. Lipid-based nanodelivery systems of curcumin: Recent advances, approaches, and applications. Food Chem. 2025;463:141193. doi: 10.1016/j.foodchem.2024.141193. PubMed DOI

Fu Y., Du Q., Cui T., Lu Y., Niu G. A pan-cancer analysis reveals role of clusterin (CLU) in carcinogenesis and prognosis of human tumors. Front. Genet. 2022;13:1056184. doi: 10.3389/fgene.2022.1056184. PubMed DOI PMC

Shiota M., Zardan A., Takeuchi A., Kumano M., Beraldi E., Naito S., Zoubeidi A., Gleave M.E. Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells. Cancer Res. 2012;72:5261–5272. doi: 10.1158/0008-5472.CAN-12-0254. PubMed DOI

Mamun M.A.A., Zheng Y.-C., Wang N., Wang B., Zhang Y., Pang J.-R., Shen D.-D., Liu H.-M., Gao Y. Decoding CLU (Clusterin): Conquering cancer treatment resistance and immunological barriers. Int. Immunopharmacol. 2024;137:112355. doi: 10.1016/j.intimp.2024.112355. PubMed DOI